Y Fujii, T Kanamaru, H Kikuchi, S Yamashita… - European Journal of …, 2011 - Elsevier Oral bioavailability of DX-9065, a factor Xa inhibitor, was only 3% when it was administered as a conventional capsule formulation in fasted humans, and was further reduced to about one-tenth when it was administered to fed humans. The poor absorption of DX-9065 ... All 3 versions
QJ Chen, WP Xiang, DK Zhang, RP Wang… - Human …, 2011 - ESHRE RESULTS Of 2445 women (aged 15–48 years) who took E-LNG-ECP with follow-up to determine pregnancy, only five pregnancies (0.2%) occurred. The efficacy of contraception was 95.3%. In total, 6.5% of women reported at least one adverse event after taking E-LNG-ECP, and ... Related articles - All 2 versions
MM Chen, CR Wang… - Yao xue xue bao= Acta …, 2011 - ncbi.nlm.nih.gov This study is to prepare the pantoprazole sodium enteric-coated tablet which is compacted by pellets. The enteric-coated pantoprazole sodium pellets were prepared by fluid bed coating technology. The pantoprazole sodium enteric-coated tablets were prepared by direct ...
[PDF] from dissolutiontech.comH Zhao, S Cafiero, Z Williams, KC Bynum… - Issues, 2011 - dissolutiontech.com ...Enteric-coatedtablets and capsules are considered delayed-release formulations because drug release is retarded until the drug product is exposed to the neutral environment of the upper intestinal tract (1). Many solid oral dosage forms require enteric coating because there is ... Related articles - View as HTML - All 2 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
